We developed an AML cell model using blood-derived monocytes that recapitulates unique features of AMs, which require TGF-β and GM-CSF for development along with IL-10 for maintenance and have a critical role in catabolizing lipid surfactant. The gene discussed is TGFB1; the disease is acute myeloid leukemia.